Evidence map›Paper›PMID 36338695›Full record

ArticleFrontiers in oncology2022

3D deep learning versus the current methods for predicting tumor invasiveness of lung adenocarcinoma based on high-resolution computed tomography images.

Yilv Lv, Ying Wei, Kuan Xu, Xiaobin Zhang, Rong Hua, Jia Huang, Min Li, Cui Tang, Long Yang, Bingchun Liu and 11 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 1 country.

Yilv LvDepartment of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Ying WeiDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Kuan XuDepartment of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Xiaobin ZhangDepartment of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Rong HuaDepartment of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Jia HuangDepartment of Oncologic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Min LiDepartment of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Cui TangDepartment of Radiology, Yangpu Hospital, Tongji University, Shanghai, China.
Long YangDepartment of Thoracic Surgery, Affiliated Hospital of Gansu Medical College, Pingliang, China.
Bingchun LiuDepartment of Thoracic Surgery, Weifang People's Hospital, Weifang, China.
Yonggang YuanDepartment of Thoracic Surgery, Qilu Hospital of Shandong University, Qingdao, China.
Siwen LiDepartment of Thoracic Surgery, Qingyuan People's Hospital, Guangzhou Medical University, Guangzhou, China.
Yaozong GaoDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Xianjie ZhangDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Yifan WuDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Yuchen HanDepartment of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhanxian ShangDepartment of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Hong YuDepartment of Radiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Yiqiang ZhanDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Feng ShiDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Bo YeDepartment of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Chest Hospital · CNUnited Imaging Healthcare (China) · CNShanghai Jiao Tong University · CNGuangzhou Medical University · CNQilu Hospital of Shandong University · CNShanghai University of Traditional Chinese Medicine · CNWeifang People's Hospital · CNYangpu Hospital of Tongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Different pathological subtypes of lung adenocarcinoma lead to different treatment decisions and prognoses, and it is clinically important to distinguish invasive lung adenocarcinoma from preinvasive adenocarcinoma (adenocarcinoma Methods: In this study, we used a deep learning approach based on 3D conventional networks to automatically predict the invasiveness of pulmonary nodules. A total of 901 early-stage non-small cell lung cancer patients who underwent surgical treatment at Shanghai Chest Hospital between November 2015 and March 2017 were retrospectively included and randomly assigned to a training set (n=814) or testing set 1 (n=87). We subsequently included 116 patients who underwent surgical treatment and intraoperative frozen section between April 2019 and January 2020 to form testing set 2. We compared the performance of our deep learning approach in predicting tumor invasiveness with that of intraoperative frozen section analysis and human experts (radiologists and surgeons). Results: The deep learning approach yielded an area under the receiver operating characteristic curve (AUC) of 0.946 for distinguishing preinvasive adenocarcinoma from invasive lung adenocarcinoma in the testing set 1, which is significantly higher than the AUCs of human experts (P<0.05). In testing set 2, the deep learning approach distinguished invasive adenocarcinoma from preinvasive adenocarcinoma with an AUC of 0.862, which is higher than that of frozen section analysis (0.755, P=0.043), senior thoracic surgeons (0.720, P=0.006), radiologists (0.766, P>0.05) and junior thoracic surgeons (0.768, P>0.05). Conclusions: We developed a deep learning model that achieved comparable performance to intraoperative frozen section analysis in determining tumor invasiveness. The proposed method may contribute to clinical decisions related to the extent of surgical resection.

Indexed as

artificial intelligencecomputer-aided diagnosisintraoperative frozen sectionlung adenocarcinomanon-small cell lung (NSCLC)tumor invasiveness

Identifiers

PMID36338695
PMCPMC9634256
OpenAlexW4306973591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.